NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q3 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,296,000 | +44.4% | 67,200 | +12.0% | 3.08% | +18.7% |
| Q4 2016 | $4,360,000 | -45.8% | 60,000 | -22.1% | 2.60% | -20.9% |
| Q3 2016 | $8,038,000 | +29.0% | 77,000 | -8.9% | 3.28% | +23.0% |
| Q2 2016 | $6,232,000 | +76.8% | 84,500 | +34.9% | 2.67% | +25.3% |
| Q1 2016 | $3,525,000 | -14.4% | 62,656 | +2.7% | 2.13% | +0.5% |
| Q4 2015 | $4,118,000 | – | 61,000 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |